6 Biotechnology Stocks to Buy Now

Advertisement

The grades of six biotechnology stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an “A” (“strong buy”) or “B” overall (“buy”) rating.

Cancer Genetics, Inc.’s (CGIX) grade is moving up to a B (“buy”) this week from last week’s C (“hold”). In Portfolio Grader’s specific subcategory of Sales Growth, CGIX also gets an A. For more information, get Portfolio Grader’s complete analysis of CGIX stock.

This week, La Jolla Pharmaceutical Company (LJPC) is making solid headway. The company’s rating improves to an A (“strong buy”) from last week’s B (“buy”) rating. For more information, get Portfolio Grader’s complete analysis of LJPC stock.

Incyte Corporation (INCY) improves from a C to a B rating this week. Incyte is using its expertise in genomics and medicinal chemistry, as well as molecular, cellular, and in vivo biology to discover and develop novel therapeutics. For more information, get Portfolio Grader’s complete analysis of INCY stock.

Ambit Biosciences Corp. (AMBI) is seeing ratings go up from a C last week to a B this week. For more information, get Portfolio Grader’s complete analysis of AMBI stock.

The rating of Progenics Pharmaceuticals, Inc. (PGNX) moves up this week, rising from a C to a B. Progenics Pharmaceuticals develops and distributes therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases. For more information, get Portfolio Grader’s complete analysis of PGNX stock.

Celladon Corporation (CLDN) gets a higher grade this week, advancing from a B last week to an A. Shares of the stock have been trading at an exceptionally rapid pace, up twofold from the week prior. For more information, get Portfolio Grader’s complete analysis of CLDN stock.

Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.


Article printed from InvestorPlace Media, https://investorplace.com/2015/05/6-biotechnology-stocks-to-buy-now-cgix-ljpc-incy/.

©2024 InvestorPlace Media, LLC